MANGIERI, DOMENICA
 Distribuzione geografica
Continente #
EU - Europa 1.342
NA - Nord America 1.140
AS - Asia 563
OC - Oceania 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 3.063
Nazione #
US - Stati Uniti d'America 1.118
IE - Irlanda 490
CN - Cina 404
UA - Ucraina 310
SE - Svezia 250
FR - Francia 88
TR - Turchia 83
IT - Italia 81
FI - Finlandia 59
SG - Singapore 59
DE - Germania 38
CA - Canada 22
GB - Regno Unito 8
BE - Belgio 7
BR - Brasile 5
AU - Australia 4
EU - Europa 4
JP - Giappone 4
HK - Hong Kong 3
IN - India 3
KR - Corea 3
CZ - Repubblica Ceca 2
IQ - Iraq 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RU - Federazione Russa 2
AT - Austria 1
CL - Cile 1
EE - Estonia 1
HU - Ungheria 1
NL - Olanda 1
PL - Polonia 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 3.063
Città #
Dublin 490
Jacksonville 219
Chandler 194
Nyköping 190
Dearborn 119
Nanjing 99
New York 65
Princeton 48
Beijing 38
Wilmington 36
Singapore 35
Ashburn 33
Ann Arbor 32
Shenyang 32
Nanchang 29
San Mateo 26
Kunming 24
Hebei 20
Helsinki 19
Kirkland 16
Albuquerque 15
Tianjin 15
Boardman 14
Changsha 14
Foggia 14
Guangzhou 14
Nuremberg 14
Des Moines 11
Kocaeli 11
Jiaxing 10
Lanzhou 10
Los Angeles 10
Ningbo 9
Shanghai 9
Zhengzhou 9
Jinan 8
Bari 7
Brussels 7
Castellana Grotte 7
Fuzhou 6
Nashville 6
Orange 6
Changchun 5
Stevenage 5
São Paulo 5
Wuhan 5
Hangzhou 4
Milan 4
Sydney 4
Chicago 3
Detroit 3
Hefei 3
Napoli 3
Norwalk 3
Taizhou 3
Washington 3
Yokohama 3
Baltimore 2
Brno 2
Cedar Knolls 2
Colombo 2
Council Bluffs 2
London 2
Munich 2
Neviano degli Arduini 2
Padova 2
Paris 2
Pinheiro de Azere 2
Rende 2
San Francisco 2
Scandiano 2
Toronto 2
Atlanta 1
Brescia 1
Budapest 1
Capurso 1
Chengdu 1
Chongqing 1
Cormeilles-en-Parisis 1
Dongyang 1
Fort Worth 1
Foshan 1
Frankfurt am Main 1
Genoa 1
Haikou 1
Hengyang 1
Houston 1
Istanbul 1
Leeds 1
Mumbai 1
Nürnberg 1
Oakland 1
Palermo 1
Parma 1
Philadelphia 1
Phoenix 1
Pinehaven 1
Pune 1
Qingdao 1
Saint Paul 1
Totale 2.104
Nome #
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality 128
MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line 90
An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells 84
Brain angiogenesis in dystrophic mdx mice is mediated by an increased proteolytic activity and VEGF expression. 84
HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic MDX mouse 83
Angiogenic response induced by acellular aortic matrix in vivo 81
Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin 79
Glial dystrophin-associated proteins, laminin and agrin, are downregulated in the brain of mdx mouse 78
Altered blood-brain barrier development in dystrophic MDX mice 74
First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant 73
Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse 73
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 73
Angiogenic response induced by acellular aortic matrix in vivo 72
Paving the path for invasion: The polyedric role of LASP1 in cancer 72
Clodronate inhibits angiogenesis in vitro and in vivo 71
Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer 69
Vascular endothelial growth factor-A, vascular endothelial growth factor receptor-2 and angiopoietin-2 expression in the mouse choroid plexuses 69
Evaluation of microvascular density in tumors: pro and contra 69
Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis 69
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma 68
Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma 68
Blood-brain barrier alterations in MDX mouse, an animal model of the Duchenne muscular dystrophy 66
Beta amyloid angiogenic activity in vitro and in vivo 65
Microcirculation density and maturity in uterine and soft tissue leiomyosarcomas: an immunohistochemical study 65
The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets 65
A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice 65
Aquaporin-4 contributes to the resolution of peritumoural brain oedema in human glioblastoma multiforme after combined chemotherapy and radiotherapy 64
Tryptase- and leptin-positive mast cells correlate with vascular density in uterine leiomyomas 63
Differential structural remodeling of the left-atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation: A morphological and molecular study 63
Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases 62
Desmin-positive pericytes in the chick embryo chorioallantoic membrane in response to fibroblast growth factor-2 61
Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium 61
Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin 59
Pentoxifylline ameliorates calcium homeostasis re generation in skeletal muscle of dystrophic mdx mice: a comparision with the effects of a combined treatment prednisolone-taurine 58
In vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycin 55
Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: Preclinical efficacy of the novel, orally available inhibitor dasatinib 55
Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse 54
Neridronate inhibits angiogenesis in vitro and in vivo 54
Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer 54
Role of tumour necrosis factor α, but not of cyclo-oxygenase-2- derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: A pharmacological approach 53
Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer 52
Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment 50
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle 49
Mast cells contribute to vasculogenic mimicry in multiple myeloma 48
Nerve growth factor as an angiogenic factor 47
Tunneling nanotubes evoke pericyte/endothelial communication during normal and tumoral angiogenesis 41
Paving the path for invasion: The polyedric role of LASP1 in cancer 41
Redox-Dependent Modulation of Human Liver Progenitor Cell Line Fate (Q1 WoS) 40
Piperine: role in prevention and progression of cancer 31
Fibrocytes in Chronic Periaortitis. Nicastro M, Vescovini R, Maritati F, Palmisano A, Urban ML, Incerti M, Fenaroli P, Peyronel F, Benigno GD, Mangieri D, Volpi R, Becchi G, Romagnani P, Corradi D, Vaglio A. Arthritis Rheumatol. 2019 Jun 24. doi: 10.1002/art.41024. [Epub ahead of print] 29
Mechanisms of chemopreventive and therapeutic proprieties of ginger extracts in cancer 26
null 21
Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading 15
Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis 7
Redox Biology and Liver Fibrosis. 5
Totale 3.271
Categoria #
all - tutte 18.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.749


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020400 0 0 0 0 67 97 81 16 64 6 65 4
2020/2021366 49 2 55 2 46 2 54 24 64 68 0 0
2021/2022251 31 3 3 0 25 5 7 21 25 35 26 70
2022/20231.191 106 44 72 35 49 109 7 100 561 19 77 12
2023/2024197 24 12 9 7 11 75 2 11 0 10 1 35
2024/2025124 51 16 22 26 9 0 0 0 0 0 0 0
Totale 3.271